Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Magnetometric Characterization of Intermediates in the Solid-State Electrochemistry of Redox-Active Metal-Organic Frameworks
Published on: June 9, 2023
Synergistic Activation of Immunogenic Cell Death and the cGAS-STING Pathway by Engineered Zinc/Manganese-Based
Bingzi Zhu1,2,3, Xiaodong Chen1,2,3, Chang Xu1,2,3
1Department of Colorectal and Anal Surgery, Zhejiang-Finland Joint Laboratory of Gastrointestinal Tumor Metabolism and Nutrition, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Abstract:
The cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) pathway is crucial for tumor immunity. However, activation of the cGAS-STING pathway alone is seldom sufficient to eliminate established tumors. Here, we report the engineering of zinc/manganese (Zn/Mn)-based metal-organic framework (MOF) nanoparticles, that is, AMP@Zn/Mn-MOF, comprising Zn/Mn-MOF nanoparticles as the carrier and the STING agonist c-di-AMP diammonium as the therapeutic drug for reinforcing antitumor immune responses. These therapeutic nanoplatforms can significantly activate the cGAS‒STING pathway and facilitate the innate immune response. Furthermore, the peroxidase (POD)-mimetic and glutathione oxidase (GSHox)-mimetic activities of AMP@Zn/Mn-MOF can significantly potentiate tumor cell death and effectively induce robust immunogenic cell death (ICD), thereby amplifying the cGAS-STING pathway. Moreover, AMP@Zn/Mn-MOF reprogrammed the immunosuppressive tumor microenvironment by promoting intratumoral lymphocyte infiltration, thereby significantly suppressing the growth of murine MC38 tumors in mice. Notably, AMP@Zn/Mn-MOF amplified the therapeutic effect of anti-programmed death ligand 1 (αPD-L1) blockade by triggering systemic antitumor responses, resulting in a notable abscopal effect to effectively inhibit distant tumors. In summary, AMP@Zn/Mn-MOF offers a nanoplatform with enhanced antitumor effectiveness through activation of the cGAS-STING pathway and ICD, suggesting that enhanced immune checkpoint blockade-based immunotherapy is promising for colon cancer treatment.
Insights
Engineered nanoparticles activate the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway and induce immunogenic cell death (ICD) to enhance antitumor immunity. This approach shows promise for colon cancer treatment, especially when combined with immune checkpoint blockade.
Area of Science:
- Immunology
- Nanotechnology
- Cancer Therapy
Background:
- The cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase-stimulator of interferon genes (cGAS-STING) pathway is vital for anti-tumor immunity.
- Activating the cGAS-STING pathway alone is often insufficient to eradicate established tumors.
- Developing strategies to enhance cGAS-STING pathway activation and overcome tumor immunosuppression is critical.
Purpose of the Study:
- To engineer novel zinc/manganese (Zn/Mn)-based metal-organic framework (MOF) nanoparticles (AMP@Zn/Mn-MOF) for enhanced antitumor immune responses.
- To investigate the therapeutic potential of AMP@Zn/Mn-MOF in activating the cGAS-STING pathway and inducing immunogenic cell death (ICD).
- To evaluate the efficacy of AMP@Zn/Mn-MOF in combination with immune checkpoint blockade for colon cancer treatment.
Main Methods:
- Fabrication of AMP@Zn/Mn-MOF nanoparticles encapsulating the STING agonist c-di-AMP diammonium.
- Assessment of cGAS-STING pathway activation and innate immune response facilitation by AMP@Zn/Mn-MOF.
- Evaluation of AMP@Zn/Mn-MOF's peroxidase (POD)-mimetic and glutathione oxidase (GSHox)-mimetic activities.
- Investigation of AMP@Zn/Mn-MOF's ability to induce immunogenic cell death (ICD) and reprogram the tumor microenvironment.
- Testing the therapeutic efficacy of AMP@Zn/Mn-MOF in murine MC38 tumor models and in combination with anti-programmed death ligand 1 (αPD-L1) therapy.
Main Results:
- AMP@Zn/Mn-MOF nanoparticles effectively activated the cGAS-STING pathway and innate immunity.
- The nanoparticles exhibited POD-mimetic and GSHox-mimetic activities, potentiating tumor cell death and inducing ICD.
- AMP@Zn/Mn-MOF reprogrammed the immunosuppressive tumor microenvironment by increasing lymphocyte infiltration.
- Significant suppression of murine MC38 tumor growth was observed with AMP@Zn/Mn-MOF treatment.
- Combination therapy with AMP@Zn/Mn-MOF and αPD-L1 blockade resulted in amplified antitumor effects and an abscopal effect against distant tumors.
Conclusions:
- AMP@Zn/Mn-MOF serves as a promising nanoplatform for enhancing antitumor immunity via cGAS-STING pathway activation and ICD induction.
- This nanoplatform effectively reprograms the tumor microenvironment and synergizes with immune checkpoint blockade.
- Enhanced immune checkpoint blockade-based immunotherapy using AMP@Zn/Mn-MOF holds significant potential for colon cancer treatment.
Related Concept Videos
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The Colonization of Land
Batteries and Fuel Cells
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

